Concord medical reports financial results for the first half of 2021

Beijing, dec. 10, 2021 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specializing in cancer care, research, and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in china, today announced its unaudited consolidated financial results for the six months ended june 30, 2021 [1]. 2021 first half highlights total net revenues were rmb192.9 million ($29.9 million) in the first half of 2021, representing a 132.4% increase from total net revenues of rmb83.0 million in the same period last year.
CCM Ratings Summary
CCM Quant Ranking